Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of osimertinib against EGFRvIII+ glioblastoma.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC, Ballman KV, Ramakrishna R, Cross DA, Markert JM, Lim M, Gilbert MR, Lesser GJ, Kwatra MM. Chagoya G, et al. Among authors: markert jm. Oncotarget. 2020 Jun 2;11(22):2074-2082. doi: 10.18632/oncotarget.27599. eCollection 2020 Jun 2. Oncotarget. 2020. PMID: 32547705 Free PMC article.
Combination strategies enhance oncolytic virotherapy.
Friedman GK, Markert JM, Gillespie GY. Friedman GK, et al. Among authors: markert jm. Oncotarget. 2017 May 23;8(21):34020-34021. doi: 10.18632/oncotarget.17643. Oncotarget. 2017. PMID: 28487503 Free PMC article. No abstract available.
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert JM, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS. Wen PY, et al. Among authors: markert jm. Clin Cancer Res. 2019 Oct 1;25(19):5799-5807. doi: 10.1158/1078-0432.CCR-19-0261. Epub 2019 Jul 18. Clin Cancer Res. 2019. PMID: 31320597 Free PMC article. Clinical Trial.
Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
Estevez-Ordonez D, Chagoya G, Salehani A, Atchley TJ, Laskay NMB, Parr MS, Elsayed GA, Mahavadi AK, Rahm SP, Friedman GK, Markert JM. Estevez-Ordonez D, et al. Among authors: markert jm. Neurosurg Clin N Am. 2021 Apr;32(2):265-281. doi: 10.1016/j.nec.2020.12.008. Epub 2021 Feb 18. Neurosurg Clin N Am. 2021. PMID: 33781507 Free PMC article. Review.
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.
Bernstock JD, Bag AK, Fiveash J, Kachurak K, Elsayed G, Chagoya G, Gessler F, Valdes PA, Madan-Swain A, Whitley R, Markert JM, Gillespie GY, Johnston JM, Friedman GK. Bernstock JD, et al. Among authors: markert jm. Hum Gene Ther. 2020 Oct;31(19-20):1132-1139. doi: 10.1089/hum.2020.101. Epub 2020 Aug 17. Hum Gene Ther. 2020. PMID: 32657154 Free PMC article.
Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme.
Griguer CE, Cantor AB, Fathallah-Shaykh HM, Gillespie GY, Gordon AS, Markert JM, Radovanovic I, Clement-Schatlo V, Shannon CN, Oliva CR. Griguer CE, et al. Among authors: markert jm. PLoS One. 2013 Apr 10;8(4):e61035. doi: 10.1371/journal.pone.0061035. Print 2013. PLoS One. 2013. PMID: 23593382 Free PMC article.
182 results